Article info
GI cancer
Original research
Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
- Correspondence to Dr Nicole C Kaneider, Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 1TN, UK; nk428{at}cam.ac.uk
Citation
Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
Publication history
- Received October 14, 2020
- Revised March 10, 2021
- Accepted March 11, 2021
- First published March 23, 2021.
Online issue publication
February 08, 2022
Article Versions
- Previous version (23 March 2021).
- Previous version (9 April 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.